Senate appropriations bill
The Democratic-controlled U.S. Senate Appropriations Committee urged HRSA to penalize drug manufacturers over 340B contract pharmacy restrictions.

Senate Appropriators Urge HRSA to Penalize Drug Makers That Impose 340B Contract Pharmacy Conditions

Federal health care officials should use fines and “any available measures” to punish drug makers that deny 340B pricing for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at